https://www.macrotrends.net/stocks/charts/IMNM/immunome/financial-statements
Ten years of annual and quarterly financial statements and annual report data for Immunome (IMNM). Income statements, balance sheets, cash flow statements and...
financial statementsimmunome
https://www.businesswire.com/news/home/20220609005251/en/Immunome-Announces-Initiation-of-Phase-1b-Study-of-IMM-BCP-01-for-the-Treatment-of-COVID-19
Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody the...
immunomeannouncesinitiationphasestudy
https://www.macrotrends.net/stocks/charts/IMNM/immunome/roa
Current and historical return on assets (ROA) values for Immunome (IMNM) over the last 10 years. Return on assets can be defined as an indicator of how...
immunomeroa